ANI PHARMACEUTICALS, INC (ANIP) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $21.33M; Long-term Debt, Excluding Current MaturitiesUSD $280.15M; Convertible Notes Payable, CurrentUSD (m); Senior Notes, CurrentUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $19.30M; Long-term Debt, Excluding Current MaturitiesUSD $286.00M; Convertible Notes Payable, CurrentUSD (m); Senior Notes, CurrentUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $17.27M; Long-term Debt, Excluding Current MaturitiesUSD $291.84M; Convertible Notes Payable, CurrentUSD (m); Senior Notes, CurrentUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $15.24M; Long-term Debt, Excluding Current MaturitiesUSD $297.68M; Convertible Notes Payable, CurrentUSD (m); Senior Notes, CurrentUSD (m).
ANI PHARMACEUTICALS, INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Convertible Notes Payable, Current USD | Senior Notes, Current USD | Long-term Line of Credit USD | Long-term Debt USD | Short-term Debt, Refinanced, Amount USD | Short-term Debt, Percentage Bearing Fixed Interest Rate pure | Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Interest Rate at Period End pure | Line of Credit Facility, Increase, Accrued Interest USD | Long-term Debt, Gross USD | Debt Instrument, Repurchase Amount USD | Debt Instrument, Interest Rate, Effective Percentage pure | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure | Debt Instrument, Unamortized Discount USD | Notes Payable, Fair Value Disclosure USD | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.33M | $280.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $19.30M | $286.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $17.27M | $291.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $15.24M | $297.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $13.22M | $301.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $11.19M | $305.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $9.17M | $309.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $7.15M | $312.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $850.00K | $284.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $850.00K | $284.61M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $850.00K | $284.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $850.00K | $285.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $850.00K | $285.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $850.00K | $285.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $850.00K | $285.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $850.00K | $285.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $850.00K | $286.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $850.00K | $286.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $850.00K | $286.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $15.93M | $186.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $15.18M | $189.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $14.44M | $168.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $13.24M | $172.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $12.79M | $175.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $12.33M | $177.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $11.87M | $188.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $9.94M | $175.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) | (m) | (m) | (m) | 7.40% | (m) | (m) | (m) | (m) |
| 2019-12-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $4.15M | $64.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $4.15M | $65.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $3.24M | $66.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $3.26M | $67.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.50% | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $5.69M | $65.95M | (m) | (m) | (m) | $134.10M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $8.64M | (m) | (m) |
| 2018-06-30 | $5.22M | $67.26M | (m) | (m) | (m) | $132.10M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $10.43M | (m) | (m) |
| 2018-03-31 | $3.81M | $68.57M | (m) | (m) | (m) | $130.20M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $12.19M | (m) | (m) |
| 2017-12-31 | $3.35M | $69.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 7.90% | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | 3.00% | $13.92M | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $128.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-29 | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | $25.00M | $126.28M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $15.64M | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | $30.00M | $124.38M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $17.33M | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | $30.00M | $122.50M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $19.00M | (m) | (m) |
| 2017-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $40.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $0.00 | (m) | (m) | (m) | $120.64M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | 7.90% | (m) | $20.64M | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $41.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | $118.81M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $22.27M | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $16.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | $116.99M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $23.87M | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | $115.20M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $25.45M | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $113.43M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | 7.80% | (m) | $27.02M | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | $115.19M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $28.56M | $131.40M | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | $113.67M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $30.08M | $163.70M | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | $112.17M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $31.58M | $165.90M | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $106.54M | (m) | (m) | (m) | (m) | (m) | (m) | $143.75M | (m) | (m) | (m) | $33.06M | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.00% | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 |
| 2013-03-31 | (m) | (m) | (m) | $8.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.00M | 6.00% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.07M |
| 2012-12-31 | (m) | (m) | (m) | $7.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | $7.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 0.38% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | $10.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 0.75% | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $1.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | $1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | $1.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $1.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |